Viral Hepatitis Monthly Newsletter

ISSUE NUMBER THREE • December 2013

White Wide Section DividerUpdated BannerWhite Wide Section Divider

Resource Guide

The Indiana Viral Hepatitis Resource Guide is a work in progress.  The information gathered through the Hepatitis Provider Inventory Survey is now being compiled into one document to create the resource guide.  The completed resource guide, upon completion, will be available on an Indiana State Department of Health webpage.  Thank you for your efforts to provide a great resource for Indiana residents. 

Green Section Divider PNG

Spotlight On...

Hepatitis C: A crisis in the African American Community   

The National Medical Association released a milestone Consensus Panel Report, titled Hepatitis C: A Crisis in the African American Community.  This report was the work of a group of physicians/researchers, federal government representatives, policy analysts, health education experts, community advocates, and more.  The group set out to address 6 key questions, and what they found, in summary, was that there was little data on the prevalence of HCV in the African American Community, African Americans have unique risk factors for HCV, there are disparities in the screening, diagnosis and treatment of HCV, and there are differences in treatment responsiveness among African Americans.  To read the full report, click here 

New Drug Approved to Treat Chronic Hepatitis C

On November 22, 2013, the U.S. Food and Drug Administration (FDA) approved Simeprevir (Olysio), a protease inhibitor from Jansen Pharmaceuticals, to treat chronic hepatitis C infections.  The new drug is indicated for adults with compensated liver disease, including cirrhosis, who have yet to receive treatment for hepatitis C, or who have not responded well to previous treatments. The FDA said simeprevir is designed as one component of a combination antiviral therapy regimen. To read more click on the following link,

Please note that the aforementioned article and specifically named products or companies mentioned in the above article does not constitute an endorsement of any product or company by the ISDH.

Green Small Divider

Hepatitis Resources

Hepatitis C Virus and Coinfection with HIV Training Manual For Treatment Advocates: 

The purpose of this manual is to provide information for you and your community. This information can be used to advocate for access to prevention and diagnosis of, and care and treatment for, hepatitis C virus (HCV).  It is

designed it to help you understand basic information about hepatitis C and coinfection with HIV: how it is transmitted, how to prevent hepatitis C, how a person can find out if he or she has hepatitis C, what happens to both HIV-negative and HIV-positive people who have hepatitis C, information used for making treatment decisions, and treatment options.

There are discussion points and action steps at the end of each section. The discussion points are intended to start conversations about the key issues raised in each section. The action steps are intended to start conversations about how to translate the key issues into advocacy in the community and to allow participants to find solutions together.

To download the Manual click here.

Hepatitis C Online Course 

The CDC supports the Hepatitis C Online Course, which has been featured in the newsletter before,  but below are the links to all four modules:

Hepatitis C Online Course is a self-study, interactive course for medical providers on Hepatitis C infection. Features include a color coded master bibliography, embedded video, and clinical calculators.  The project is brought to you by the University of Washington in collaboration with the International Antiviral Society-USA (IAS-USA). Free CME credit and free CNE credit are available. Funded by the Centers for Disease Control and Prevention.

Green Section Divider PNG

Other Resources

Dialysis Safety website
Infections are a leading cause of death in hemodialysis patients. Receiving safe care and avoiding infectious complications are of utmost importance to patients. Reducing infections requires diligence from both providers and patients. CDC is providing three new resources for preventing infections in dialysis patients:

The poster and pocket guide are available for order through the CDC-INFO warehouse.  Click to edit this placeholder text.

Green Section Divider PNG

Viral Hepatitis Updates & News

Experimental Hepatitis C Drug May Treat the Untreatable  

A new drug, a single pill combined two investigational drugs, sofosbuvir and ledipasvir.  In clinical trials showed success in treating hepatitis C virus (HCV) infection in nearly all patients who took it (Lancet, 2013).

The study author stated, "Ninety-five percent of patients new to hepatitis C virus therapy who took eight weeks of the sofosbuvir/ledipasvir combination tablet were HCV undetectable 24 weeks after therapy ended..." To the full article click here.

Influence of HIV Infection on Response to Tenofovir in Patients with Chronic Hepatitis B

HIV worsens the natural history of chronic hepatitis B virus (HBV) infection. Suppression of HBV replication slows progression of liver damage. Information about the influence of HIV on response to tenofovir in HIV/HBV-coinfected patients is scarce.  All individuals with persistent HBsAg+ at four clinics in Spain were identified. Information from the subset that initiated tenofovir therapy was examined.  In multivariate analysis, baseline serum HBV-DNA was the only predictor of virological response to tenofovir.  In conclusion,  The antiviral efficacy of tenofovir is similar in HIV/HBV-coinfected and HBV-monoinfected patients, achieving undetectable HBV-DNA nearly 90% of patients at week 96 of therapy.  Read the full article by clicking here

Primary Care Options for Hepatitis C Treatment Cost-Effective

 The Extension for Community Healthcare Outcomes (ECHO) program, which trains primary care physicians to treat patients infected with hepatitis C in underserved communities, is cost-effective, a new analysis shows. 

The ECHO program, developed at the University of New Mexico Health Sciences Center, uses teleconferencing to help primary care physicians and specialists at the university comanage patients with chronic hepatitis C infection in 16 underserved rural areas and 5 correctional facilities.

Initial efficacy findings for 407 patients showed that the rates of sustained viral response at ECHO sites were nearly identical to those at university clinics (58.2% vs 57.5%) (N Engl J Med. 2011;364:2199-2207).  To read more, click here.



Small Green Section DividerSmall Green Section Divider


HIV/Viral Hepatitis/STD Community Service and Effective Resources System Meeting  for District 6

Where: Cornerstone Center for the Arts, 520 East Main Street, Muncie, Indiana 47305

Date: Tuesday, December 10, 2013

Time: 10:00 a.m. to 2:00 p.m. 

Participants will collaborate with each other to ensure that individuals in the community are referred to the most appropriate services within East Central Indiana based upon individual needs and the resources of the organizations.

This meeting incorporates all of the providers in Indiana State Department of Health HIV/Viral Hepatitis/STD Region 6.

Any providers or service providers within this region are invited to attend. Participants will help assist organizations in providing the best services for the community and share knowledge of the services currently being provided. Most of these services are free or low-cost services available to individuals. 

 The goal is to identify gaps in resources and the expansion of key services within the community.

To register, please go to: and submit the registration form before the end of business on November 15, 2013.

Women & AIDS Conference 20th Anniversary

Looking Back, Living Forward - HIV in our Community 

Please join the Women & AIDS Committee in celebrating the 20th Anniversary of the Women & AIDS Conference on December 5th 2013 in South Bend, Indiana as they "Look Back" and continue "Living Forward". 

The Women & AIDS Committee has held annual conferences which have hosted a variety of informational workshops and inspiring topics. These topics include the many issues of which the men, women and children living with HIV/AIDS are challenged with in everyday life such as HIV/AIDS in our schools, in our workforce, and in our communities. By working together on these and many other topics and issues, we can reduce the spread of HIV in our communities. 

Thursday, December 5th 2013

9am - 3pm

Logan Center

2505 E Jefferson St.

South Bend, IN 46615

Keynote Speaker

Mrs. Debra Stanley

(Imani Unidad)


--Religion/AIDS 101

--Education & Prevention

--A Day in the Life

--Resources in our Community

Lunch will be provided

*6 hours of HIV/AIDS Education Certificates will be given


For more information please contact: 

Latorya Greene

Director of Prevention

AIDS Assist or North Indiana




All Registration must be made by Monday, December 2nd 2013

Individuals - $8 per person

Group of 5 or more - $7.00 per person 

Please make all checks payable to 

AIDS Assist of North Indiana

(Women & AIDS Conference)

Small Green Section Divider